G1 builds out executive team as it eyes important results in 2018
November 08, 2017 at 12:45 PM EST
Roughly four months after naming former GlaxoSmithKline CEO Sir Andrew Witty to its board of directors, Research Triangle Park-based G1 Therapeutics has a made a pair of additions to its executive team.
